Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Share buy-back programme - week 20
-
NEXEN TIRE’s official partner of Manchester City crowned 2023/24 Premier League Champions
-
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
-
Municipality Finance issues EUR 40 million notes under its MTN programme
-
Launch of an any and all cash tender offer to repurchase its bonds due May 2025 and potential issuance of new sustainability-linked bonds
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income plc
-
Resume trading in SKAGEN and Storebrand funds
-
The increase of the share capital related to the option programme, is entered in the Commercial Register
-
Sydbank to acquire Coop Bank A/S
-
Tokenovate collaborates with Land Carbon to design tokenised high integrity carbon credits optimising vital funding for peatland restoration and preservation
-
Bedford Metals Completes Close Lake Uranium Project Option Agreement
-
Equinor ASA: Notifiable trading
-
Progress on share buyback programme
-
-
Transaction in Own Shares
-
Subsea7 share repurchases
-
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Presto Automation Announces Fiscal Third Quarter 2024 Financial Results
-
-
Nextensa : RESULTS ON Q1 2024
-
Litchfield Hills Research reiterates buy recommendation at $10.00 per share
-
DNO to Hold Fixed Income Investor Meetings
-
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
-
Start of Day Message
-
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
-
Planisware - Q1 2024 revenue - Strong start of the year and dynamic commercial momentum
-
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
-
Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
-
Idorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable value
-
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Vestis Corporation (VSTS)
-
CANON DRIVES INTO GOLF MARKET WITH ANNOUNCEMENT OF POWERSHOT GOLF DIGITAL LASER RANGEFINDER
-
LUNA Stock News: Contact Robbins LLP for Information About the Class Action Involving Luna Innovations Incorporated and the Pending Lead Plaintiff Deadline
-
Parks! America Issues Open Letter to Shareholders, “Your Choice is Now Clear”
-
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Teladoc Health, Inc. (TDOC)
-
Volvo Trucks North America and Volvo Financial Services Launch Volvo on Demand to Accelerate Battery-Electric Vehicle Adoption
-
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
-
GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on Behalf of Grocery Outlet Stockholders and Encourages Investors to Contact the Firm
-
VESTIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Vestis Corporation and Encourages Investors to Contact the Firm
-
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
-
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
-
West Coast Community Bancorp and 1st Capital Bancorp Announce Agreement to Merge
-
Owens-Brockway Glass Container Inc. Announces Pricing of Senior Notes Offering
-
AST Mining Unveils Free Cloud Mining, Paving the Way for Seamless Crypto Investment in 2024.
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
-
MINILUXE REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024
-
S&P reviews Banco Inter's outlook to Stable and reaffirms its "brAA+" rating
-
S&P reviews Banco Inter's outlook to Stable and reaffirms its "brAA+" rating

